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Peroxiredoxin-2 as Circulating Biomarkers for Small
Abdominal Aortic Aneurysm Progression: A Proteomic
View
Sigitas Urbonavicius1, Jes S. Lindholt1, Grazina Urbon-
aviciene1, Eskild W. Henneberg1, Bent Honoré2. 1Depart-
ment of Vascular Surgery, Regionshospital Viborg, Viborg,
Denmark; 2Institute of Medical Biochemistry, University
of Aarhus, Aarhus, Denmark
Objectives: Proteomic is evolving as an important re-
search technique in cardiovascular disease. Identification of
circulating biomarkers for the progression and rupture of
abdominal aortic aneurysms (AAA) could improved selec-
tion of patients to AAA repair. We aimed to investigate the
basic serum proteins composition and to associate with
different AAA expansion rate by proteomic.
Methods: A proteomic approach was used consisting
of two-dimensional gel electrophoresis (2D-PAGE) and
mass spectrometry (MS) to identify differentially expressed
proteins in sera from 15 AAA operated patients. The per-
centage volumes of protein-spots with AAA were deter-
mined by computerized imaging, and associated with AAA
expansion rate. Relevant protein-spots were in-gel digested
and identified by liquid chromatography - tandem mass
spectrometry (LC-MS/MS).
Results: Five hundred and thirty-two spots were dem-
onstrated on the gels. Fourteen protein spots correlated
strongly with AAA expansion rate (rho/-0.6). Nine
protein spots showed positive and negative correlation
represented fragments of albumin, highly abundant in se-
rum. The five negatively correlated spots were apolipopro-
tein A-IV (rho  0.67, p  0.038); fibrinogen--chain
(rho  0.66, p  0.036); haptoglobin in two spots
(rho  0.66, p  0.038 and rho  0.65, p  0.042);
Ig--1 or 2 chain C (rho  0.76, p  0.011) and
peroxiredoxin-2 (rho0.62, p 0.05). Interestingly, in
our previous study peroxiredoxin-2 was up-regulated 8.1-
fold in the ruptured AAA group compared with nonrup-
tured AAA as determined by 2D-PAGE. Western blot
analysis confirmed the significant up-regulation of perox-
iredoxin-2 in ruptured aortic tissue.
Conclusions: Collectively studies provide support for
the hypothesis that oxidative stress is an important component
in formation and enlargement of AAA through activation of
MMPs and induction of apoptosis within the aortic wall.
Larger studies are required to confirm the potential and clin-
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Objectives: Current models of aortic aneurysms for
stent-graft assessment and development are anatomically
correct but do not match physiological properties of living
aortic tissue. Our aim was to manufacture new aortic model
with physiological properties from biocompatible and vis-
coelastic polymer developed by our group.
Methods: Porcine abdominal aortas were acquired to es-
tablish values for compliance. Aortic model was manufactured
using nanocomposite polymer based on polyhedral oligomeric
silsesquioxanes (POSS) and poly (carbonate-urea)-urethane
(PCU). Commercially available latex mock aorta was used
for comparison. A pulsatile flow phantom perfused aortas
and synthetic tubes at physiological pulse pressure and
flow. Intraluminal pressure was measured using Millar
Mikro-tip catheter transducer and vessel wall motion was
determined with duplex ultrasonography. Diametrical
compliance and stiffness index were calculated over mean
pressures 30, 60, 90 and 110 mm Hg.
Results: Flow circuit haemodynamics including pulse
pressure, flow rate, perfusate temperature and viscosity were
similar for porcine aorta and synthetic tubes. Compliance of
aorta ranged from 2.97 0.72 (mean s.d.) to 1.42 0.37
percent per mm of HgX10-2. Using one-way analysis of
variance and Bonferroni Multiple Comparison Test, polymer
modelwas significantlymore compliant (range3.661.05 to
2.720.28; p0.05*) as compared to porcine aortawith no
significant difference in elastic stiffness (mean difference
30.27, p0.05) but similar anisotropic behaviour. Latex
tubes exhibited compliance similar to aorta (0.87  0.24 to
0.86  0.2; p  0.05) only at low pressures however on
increase in pressure from mean of 90 mm Hg, these tubes
failed by significant distension.
Conclusions: We have developed physiologically rele-
vant aortic model exhibiting compatible anatomy, compli-
ance and viscoelasticity which could be used for long-term
fatigue analysis of vascular stents and grafts. The commer-
cially available latex mock aortas can fail at physiological
pressures.
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Nogo-B Protein Modulates Intimal Thickening Dur-
ing Vein Graft Adaptation
Yuka Kondo, Akihito Muto, Tai Yi, Amanda Feigel, Ken-
neth Ziegler, Lynn Model, Sammy Eghbalieh, Jun Yu,
William Sessa, Alan Dardik. Yale University, New Haven,
CT
Objectives: Nogo-B is a protective factor in the vascu-
lar system, limiting the response to arterial injury. We
hypothesized that Nogo-B would diminish in thickened
vein grafts after exposure to arterial levels of pressure and
shear stress. We examined the expression of Nogo-B, as
well as its three receptors, Nogo-receptor (NgR), Nogo-B-
receptor (NgBR), and PirB (Paired immunoglobulin-like
receptor B), during mouse vein graft adaptation.
Methods:The intrathoracic inferior vena cava (IVC) of
C57Bl/6 (WT) or Nogo-A/B knockout (Nogo-KO) mice
was harvested and implanted as an interposition vein graft
into WT mice. Vein grafts were harvested and analyzed
after 3 weeks. mRNA transcript levels of Nogo-B, NgR,
NgBR, PirB and GAPDH were measured by qPCR. Im-
munohistology (IHC) and Western blotting were per-
formed using the antibodies: Nogo (N18: Santa Cruz),
Nogo-B (1761), F4/80 (AbD serotec).
Results: All vein grafts showed significant wall thick-
ening, with increased thickening in Nogo-KO compared to
WT grafts (0.125  .025 mm vs 0.043  0.003 mm, n 
4; p 0.05). InWT vein grafts, Nogo-B protein levels were
strongly increased compared to preimplantation IVC (IHC
density 6-fold, Western blot density 10-fold). Nogo-B
RNA transcripts were increased 2-fold in the vein graft
compared to IVC. Transcript levels of the NgR and NgBR
were unchanged in vein grafts compared to IVC, whereas
PirB transcript levels were increased approximately 20-fold
(n  3; p  0.05).
Conclusions: Nogo-B transcripts and protein, as well
as transcripts for its PirB receptor, were increased during
vein graft adaptation, suggesting that graft adaptation is
not a response to injury, but an adaptive remodeling re-
sponse. Nogo-B is a factor limiting this adaptive response,
and may signal via the PirB receptor. These results suggest
that Nogo-B signaling is a mechanism of vein graft adapta-
tion and might be a therapeutic target for human trials
targeting vein graft disease.
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Objectives:The 26S proteasome degrades themajority
of proteins in eukaryotic cells. The 11S proteasome activa-
tor (PA28) binds to the proteasome and increases its ability
to degrade small peptides. Expression of the PA28 subunits
(, , ) is induced by interferon- stimulation. Since
inflammation plays a role in the development of neointimal
hyperplasia, and since nitric oxide (NO) reduces neointimal
hyperplasia in animal models, we hypothesize that NO will
reduce the expression of PA28.
Methods: The carotid artery balloon injury model was
performed in 11-week-old male Sprague Dawley rats. Treat-
ment groups included injury or injuryPROLI/NO (20 mg).
PA28 subunit expression was assessed by Western blot
analysis on homogenized arteries excised 3 days after injury
(n  3/group) and by immunofluorescent staining of
carotid artery sections harvested 14 days after injury (n 
3/group). Contralateral arteries served as uninjured con-
trols.
Results: Following arterial injury, Western blot analy-
sis showed that expression of the PA28,  and  subunits
remained unchanged. However, after injury and treatment
with NO, expression of the PA28,  and  subunits
decreased substantially in the carotid artery lysates (1.9-,
2.3- and 3.4-fold, respectively). Immunofluorescence
staining of carotid artery sections following injury revealed
a slight increase in the expression of PA28 in the adven-
titia, perhaps due to multimeric PA28 binding the anti-
body more effectively. The expression of PA28 and 
following injury were relatively similar to control. NO
significantly decreased the expression of PA28 in the
media, whereas NOdecreased the expression of PA28 and
 throughout the neointima, media and adventitia.
Conclusions:We report that NOdecreased the expres-
sion of PA28 ,  and  following arterial injury in vivo.
Since the PA28 subunits are involved in the breakdown of
peptides during inflammation, PA28 inhibition may be one
mechanism by which NO inhibits neointimal hyperplasia.
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